PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 247 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $798 | +14.8% | 60 | 0.0% | 0.00% | – |
| Q1 2023 | $695 | +41.5% | 60 | 0.0% | 0.00% | – |
| Q4 2022 | $491 | – | 60 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 60 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 60 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 60 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | – | 60 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrone Advisors, LLC | 16,415,933 | $218,331,909 | 38.11% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,015,495 | $26,806,084 | 19.75% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $19,469,498 | 6.11% |
| Iron Triangle Partners LP | 2,400,000 | $31,920,000 | 4.27% |
| Jackson Square Partners, LLC | 8,517,624 | $113,284,399 | 3.30% |
| BOURNE LENT ASSET MANAGEMENT INC | 580,000 | $7,714,000 | 2.69% |
| ARK Investment Management | 26,634,620 | $354,240,443 | 2.34% |
| ARDSLEY ADVISORY PARTNERS LP | 906,000 | $12,049,800 | 2.04% |
| Avidity Partners Management LP | 4,337,400 | $57,687,420 | 2.02% |
| Nikko Asset Management Americas, Inc. | 13,649,948 | $181,271,309 | 1.91% |